BOTHELL, Wash., June 5 /PRNewswire-FirstCall/ -- Cardiac Science Corporation (Nasdaq: CSCX), a global leader in advanced cardiac diagnosis, resuscitation, rehabilitation, and informatics products, announced today that it will present at the Seventh Annual Needham & Company Biotechnology and Medical Technology Conference at the New York Palace Hotel. Michael Matysik, senior vice president and chief financial officer, will review the Company's business strategy and recent financial results during the Company's presentation on Thursday, June 12, 2008 at 2:30 p.m. Eastern Time.
Attendance at the conference is by invitation only. Cardiac Science will offer a live webcast of its presentation, which may be accessed at the Company's website at http://www.cardiacscience.com. An archived replay of the presentation will also be available following the live presentation and can be accessed at http://www.cardiacscience.com for 90 days.
About Cardiac Science
Cardiac Science develops, manufactures, and markets a family of
advanced diagnostic and therapeutic cardiology devices and systems,
including automated external defibrillators (AEDs), electrocardiograph
devices (ECGs), cardiac stress systems and treadmills, Holter monitoring
systems, hospital defibrillators, cardiac rehabilitation telemetry systems,
and cardiology data management systems (informatics) that connect with
hospital information (HIS), electronic medical record (EMR), and other
information systems. The Company sells a variety of related products and
consumables, and provides a portfolio of training, maintenance, and support
services. Cardiac Science, the successor to the cardiac businesses that
established the trusted Burdick(R), HeartCentrix(R), Powerheart(R), and
Quinton(R) brands, is headquartered in Bothell, Washington. With customers
in more than 100 countries worldwide, the company has operations in North
America, Europe, and Asia. For information, call 425.402.2000 or visit
Company Contact: Investor Contact: Media Contact:
Mike Matysik Jenifer Kirtland Christopher Gale
Cardiac Science Corporation EVC Group, Inc. EVC Group, Inc.
Sr. Vice President and CFO (415) 896-6820 (201) 646-5431
(425) 402-2009 (203) 570-4681
|SOURCE Cardiac Science Corporation|
Copyright©2008 PR Newswire.
All rights reserved